Literature DB >> 18413538

Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy.

Carlos Bianciotto, Carol L Shields, Brian Kang, Jerry A Shields.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413538     DOI: 10.1001/archopht.126.4.578

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  3 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.

Authors:  Chikae Nakashima; Hiroshi Keino; Takayo Watanabe; Wakako Taki; Annabelle A Okada
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

3.  Emerging roles for antiangiogenesis factors in management of ocular disease.

Authors:  Muhammad Usman Saeed; Evangelia Gkaragkani; Kashif Ali
Journal:  Clin Ophthalmol       Date:  2013-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.